An underground economy for unapproved slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, based on new investigations.
Experimental Treatment Gaining Traction Online
The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are urged to contact these profiles directly for source information, while also receiving discount codes.
Active Commerce on Social Networks
Additionally, a robust trade exists on messaging services, where groups with thousands of members share comparison images, administration instructions and claims of next-day UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Experts Voice Worries
However, doctors and pharmacists have warned that the distribution of what remains an unapproved medication in the UK is a cause for concern and could lead to users injecting substances of unknown origin.
Some experts stated the demand for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and customer laws, risking fines, legal action or imprisonment.
Service Reaction and Content Removal
Based on TikTok, the service has removed problematic material and banned associated hashtags and search suggestions. The organization said it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Research also discovered groups with up to nine thousand participants marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, populated with images of weight loss, positive testimonials and detailed guides for preparing or administering at home.
Within minutes of entering one group, a vendor posted contact information, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, health issues or previous experience.
Product Details and Costs
Inside these groups, messages display dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for Telegram said it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they cannot confirm. Although the science behind this drug is valid, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has already encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to possibly serious medical dangers”.